amitriptyline has been researched along with Angor Pectoris in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shubina, TI | 1 |
Zaĭtsev, VP | 1 |
Sweet, RL | 1 |
Sheffield, LT | 1 |
1 trial available for amitriptyline and Angor Pectoris
Article | Year |
---|---|
[Results of comparative studies of the effects of antidepressants pyrazidole and amitriptyline on stenocardia].
Topics: Adult; Aged; Amitriptyline; Angina Pectoris; Carbazoles; Clinical Trials as Topic; Humans; Male; Mid | 1988 |
1 other study available for amitriptyline and Angor Pectoris
Article | Year |
---|---|
Myocardial infarction after exercise-induced electrocardiographic changes in a patient with variant angina pectoris.
Topics: Amitriptyline; Angina Pectoris; Arteriosclerosis; Catheterization; Diabetes Complications; Electroca | 1974 |